Christopher M Prior

US Patent:

7507414, Mar 24, 2009

Filed:

Mar 14, 2005

Appl. No.:

11/078663

Inventors:

Craig A. Rosen - Laytonsville MD, US
Homayoun Sadeghi - Doylestown PA, US
Christopher P. Prior - Rosemont PA, US
Andrew J. Turner - Eagleville PA, US

Assignee:

Human Genome Sciences, Inc. - Rockville MD

International Classification:

A61K 39/00

US Classification:

4241921, 514 12, 530350

Abstract:

The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.

US Patent:

20030171267, Sep 11, 2003

Filed:

Apr 12, 2001

Appl. No.:

09/833117

Inventors:

Craig Rosen - Laytonsville MD, US
Homayoun Sadeghi - Doylestown PA, US
Christopher Prior - Rosemont PA, US
Andrew Turner - Eagleville PA, US

International Classification:

A61K038/38
C07K014/765

US Classification:

514/012000, 530/363000

Abstract:

The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disordrs or conditions using albumin fusion proteins of the invention.

US Patent:

20100189686, Jul 29, 2010

Filed:

Feb 4, 2009

Appl. No.:

12/365878

Inventors:

Craig A. Rosen - Laytonsville MD, US
Homayoun Sadeghi - Doylestown PA, US
Christopher P. Prior - Rosemont PA, US
Andrew J. Turner - Eagleville PA, US

International Classification:

A61K 38/38
C07K 19/00
C07H 21/04
C12N 15/63
C12N 1/20
C12N 5/10
C12N 1/19
C12P 21/00

US Classification:

424 856, 530351, 536 234, 4353201, 4352523, 43525235, 435348, 4352542, 435358, 435 697

Abstract:

The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.